Related references
Note: Only part of the references are listed.Structural Basis for Matrix Metalloproteinase 1-Catalyzed Collagenolysis
Ivano Bertini et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1
Szymon W. Manka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Role of serum matrix metalloproteinase-2 and-9 to predict breast cancer progression
Suprava Patel et al.
CLINICAL BIOCHEMISTRY (2011)
Regulation of matrix metalloproteinase activity in health and disease
Elin Hadler-Olsen et al.
FEBS JOURNAL (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy
Tibor Szarvas et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Validation of Circulating MMP-7 Level as an Independent Prognostic Marker of Poor Survival in Urinary Bladder Cancer
Tibor Szarvas et al.
PATHOLOGY & ONCOLOGY RESEARCH (2011)
Matrix Metalloproteinase-9 Is a Prognostic Marker to Predict Survival of Patients Who Underwent Surgery Due to Rectal Carcinoma
Saulius Svagzdys et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab
Xabier Garcia-Albeniz et al.
TUMOR BIOLOGY (2011)
MMP-7 as a prognostic marker in colorectal cancer
Selja Koskensalo et al.
TUMOR BIOLOGY (2011)
Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer
Safwan Escaff et al.
WORLD JOURNAL OF UROLOGY (2011)
Tissue inhibitors of metalloproteinases
Gillian Murphy
GENOME BIOLOGY (2011)
Matrix Metalloproteinases and Angiogenic Factors Predictors of Survival after Radical Prostatectomy for Clinically Organ-Confined Prostate Cancer?
Silvan Boxler et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Serum Matrix-Metalloproteinase-1 is a Bona Fide Prognostic Marker for Colorectal Cancer
Kouichirou Tahara et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Study of matrix metalloproteinases and their inhibitors in prostate cancer
S. Escaff et al.
BRITISH JOURNAL OF CANCER (2010)
MMP-9 (Gelatinase B) Expression is Associated With Disease-Free Survival and Disease-Specific Survival in Colorectal Cancer Patients
Riyad Bendardaf et al.
CANCER INVESTIGATION (2010)
The Role of Matrix Metalloproteinase 2 on the Survival of Patients with Non-Small Cell Lung Cancer: A Systematic Review with Meta-Analysis
Qian Qian et al.
CANCER INVESTIGATION (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
The clinical implications of MMP-11 and CK-20 expression in human breast cancer
Chun-Wen Cheng et al.
CLINICA CHIMICA ACTA (2010)
Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer
Jose M. del Casar et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Gelatin In Situ Zymography on Fixed, Paraffin-embedded Tissue: Zinc and Ethanol Fixation Preserve Enzyme Activity
Elin Hadler-Olsen et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2010)
Prognostic Stratification of Stage IIIA pN2 Non-small Cell Lung Cancer by Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data An Alpe Adria Thoracic Oncology Multidisciplinary Group Study (ATOM 014)
Francesco Grossi et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients
Min Li et al.
LUNG CANCER (2010)
Activity of MMP-2 and MMP-9 in sera of breast cancer patients
Sandra Stankovic et al.
PATHOLOGY RESEARCH AND PRACTICE (2010)
Expression of potential molecular markers in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy
Hideaki Miyake et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Updated Biological Roles for Matrix Metalloproteinases and New Intracellular Substrates Revealed by Degradomics
Georgina S. Butler et al.
BIOCHEMISTRY (2009)
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature
Andrea Koehrmann et al.
BMC CANCER (2009)
Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease
Xeni Provatopoulou et al.
BMC CANCER (2009)
Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas
J. M. Del Casar et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Salivary analysis of oral cancer biomarkers
T. Shpitzer et al.
BRITISH JOURNAL OF CANCER (2009)
Matrix metalloproteinase proteomics: substrates, targets, and therapy
Charlotte J. Morrison et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Genetic polymorphisms in the MMP-7 gene and breast cancer survival
Alicia Beeghly-Fadiel et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Three Immunomarker Support Vector Machines-Based Prognostic Classifiers for Stage IB Non-Small-Cell Lung Cancer
Zhi-Hua Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma
Sandro J. Martins et al.
LUNG CANCER (2009)
OPINION Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting
Georgina S. Butler et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Clinical Significance of the Measurements of Serum Matrix Metalloproteinase-9 and Its Inhibitor (Tissue Inhibitor of Metalloproteinase-1) in Patients With Pancreatic Cancer Metalloproteinase-9 as an Independent Prognostic Factor
Barbara Mroczko et al.
PANCREAS (2009)
Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database
P. M. McGowan et al.
ANNALS OF ONCOLOGY (2008)
Tumor-derived Matrix Metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer
Bin Zhang et al.
BMC CANCER (2008)
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer
Hui Liu et al.
CANCER SCIENCE (2008)
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas
Azizbek Ramankulov et al.
CANCER SCIENCE (2008)
The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients
Barbara Mroczko et al.
CLINICA CHIMICA ACTA (2008)
Urinary biomarkers predict brain tumor presence and response to therapy
Edward R. Smith et al.
CLINICAL CANCER RESEARCH (2008)
Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species
Roopali Roy et al.
CLINICAL CANCER RESEARCH (2008)
Identification of Pro-MMP-7 as a serum marker for renal cell carcinoma by use of proteomic analysis
Gaiane Sarkissian et al.
CLINICAL CHEMISTRY (2008)
Circulating Levels of VCAM and MMP-2 May Help Identify Patients with More Aggressive Prostate Cancer
Concetta Cicco et al.
CURRENT CANCER DRUG TARGETS (2008)
The regulation of matrix metalloproteinases and their inhibitors
Ian A. Clark et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1
Yukihiko Aikawa et al.
NATURE BIOTECHNOLOGY (2008)
CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate Cancer
Wei-de Zhong et al.
ONCOLOGY (2008)
Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities
William G. Stetler-Stevenson
SCIENCE SIGNALING (2008)
Cancer invasion and metastasis: changing views
M. J. Duffy et al.
JOURNAL OF PATHOLOGY (2008)
Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung
Norihiro Takemoto et al.
LUNG CANCER (2007)
The other side of MMPs: Protective roles in tumor progression
Michelle D. Martin et al.
CANCER AND METASTASIS REVIEWS (2007)
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer
Dage Liu et al.
LUNG CANCER (2007)
Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention
D. Iliopoulos et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine
Sanaa Eissa et al.
EUROPEAN UROLOGY (2007)
Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients
N. G. Hurst et al.
BRITISH JOURNAL OF CANCER (2007)
Tumour micro environment -: Opinion -: Emerging roles of proteases in tumour suppression
Carlos LOpez-Otin et al.
NATURE REVIEWS CANCER (2007)
Prognostic significance of matrix metalloproteinases-1,-2,-7 and-13 and tissue inhibitors of metalloproteinases-1,-2,-3 and-4 in colorectal cancer
Marja Hilska et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34
H. J. Kim et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Study of matrix metalloproteinases and their inhibitors in breast cancer
F. J. Vizoso et al.
BRITISH JOURNAL OF CANCER (2007)
The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer
A. Hettiaratchi et al.
BRITISH JOURNAL OF CANCER (2007)
Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer
O. Schwandner et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma
E. Mylona et al.
HISTOPATHOLOGY (2007)
Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population
Sue Wilson et al.
BMC CANCER (2006)
Understanding the role of tissue degrading enzymes and their inhibitors in development and disease
Tim E. Cawston et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2006)
Circulating MMP2 and MMP9 in breast cancer - Potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories
Stella B. Somiari et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metal loproteinase-12 in non-small cell lung cancer
Heath B. Acuff et al.
CANCER RESEARCH (2006)
Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer
Chung-Ping Hsu et al.
LUNG CANCER (2006)
Tissue MMP-2/TIMP-2-complex are better prognostic factors than serum MMP-2, MMP-9 or TIMP-1 in Stage I-III lung carcinoma
S. Hoikkala et al.
CANCER LETTERS (2006)
Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma
WS Wang et al.
CARCINOGENESIS (2006)
Pericellular proteases in angiogenesis and vasculogenesis
VWM van Hinsbergh et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor β correlates with the survival of breast cancer patients.
AY Savinov et al.
CANCER RESEARCH (2006)
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer -: Relation to clinicopathological factors, β-catenin and prognosis
T Leinonen et al.
LUNG CANCER (2006)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
Matrix metalloproteinases: roles in cancer and metastasis
B Fingleton
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer
SJ Kim et al.
LUNG CANCER (2005)
The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients
CA Fernández et al.
CLINICAL CANCER RESEARCH (2005)
Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent
V Gouyer et al.
CANCER (2005)
Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs
P Cuniasse et al.
BIOCHIMIE (2005)
Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer
G Morgia et al.
UROLOGICAL RESEARCH (2005)
Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer
Y Shimanuki et al.
LUNG (2005)
Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors
PAM Snoek-van Beurden et al.
BIOTECHNIQUES (2005)
Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis
LD Chung et al.
EMBO JOURNAL (2004)
Type IV collagenase (matrix metalloproteinase-2 and-9) in prostate cancer
L Zhang et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2004)
Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with special reference to activator protein-2, HER2, and prognosis
JM Pellikainen et al.
CLINICAL CANCER RESEARCH (2004)
A protective role for matrix metalloproteinase-3 in squamous cell carcinoma
LJ McCawley et al.
CANCER RESEARCH (2004)
Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies
AR Folgueras et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2004)
Loss of collagenase-2 confers increased skin tumor susceptibility to male mice
M Balbín et al.
NATURE GENETICS (2003)
Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells
TN Mitropoulou et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells
B Mathisen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Strategies for MMP inhibition in cancer:: Innovations for the post-trial era
CM Overall et al.
NATURE REVIEWS CANCER (2002)
Structural differences of matrix metalloproteinases with potential implications for inhibitor selectivity examined by the GRID/CPCA approach
GE Terp et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Tissue levels of active matrix metalloproteinase-2 and-9 in colorectal cancer
ET Waas et al.
BRITISH JOURNAL OF CANCER (2002)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
Real-time zymography and reverse zymography: A method for detecting activities of matrix metalloproteinases and their inhibitors using FITC-labeled collagen and casein as substrates
S Hattori et al.
ANALYTICAL BIOCHEMISTRY (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Timeline - Matrix metalloproteinases: a tail of a frog that became a prince
CE Brinckerhoff et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Stromelysin 3 expression: A useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans
B Cribier et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas
T Masaki et al.
BRITISH JOURNAL OF CANCER (2001)
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
G Bergers et al.
NATURE CELL BIOLOGY (2000)
Identification of the 183RWTNNFREY191 region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity
L Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
